Howard Mayer

Insider Reports History

Entity
Individual
Location
C/O Genocea Biosciences, Inc., 100 Acorn Park Drive, 5 Th Floor, Cambridge, MA
Signature
/s/ Noel Donnelly, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard Mayer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Adagio Therapeutics, Inc. Director Stock Option (Right to Buy) 75K Jun 22, 2022 Direct
PepGen Inc. Director Stock Option (Right to Buy) 8.67K Jun 20, 2024 Direct
Entasis Therapeutics Holdings Inc. Director Common Stock 0 $2.20 Jul 11, 2022 Direct
Entasis Therapeutics Holdings Inc. Director Stock Option (right to buy) 0 Jul 11, 2022 Direct

Insider Reports Filed by Howard Mayer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PEPG PepGen Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
PEPG PepGen Inc. Nov 10, 2023 1 $0 4 Nov 14, 2023 Director
PEPG PepGen Inc. Nov 10, 2023 0 $0 3 Nov 14, 2023 Director
ETTX Entasis Therapeutics Holdings Inc. Jul 7, 2022 4 -$109K 4 Jul 11, 2022 Director
IVVD Adagio Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
ETTX Entasis Therapeutics Holdings Inc. Jan 18, 2022 1 $0 4 Jan 19, 2022 Director
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 1 $0 4 Aug 9, 2021 Director
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 0 $0 3 Aug 5, 2021 Director
ETTX Entasis Therapeutics Holdings Inc. Jul 16, 2021 2 $0 4 Feb 15, 2022 Director